Most TB-500 protocols use cycling approaches (4-6 weeks on, 2-4 weeks off) to optimize results and manage costs, though continuous use hasn't shown significant safety concerns in research. Cycling may prevent receptor downregulation and maintain effectiveness. Chronic conditions might warrant longer continuous use under medical supervision.
TB-4 treatment protocols